Abstract Details
Activity Number:
|
232
|
Type:
|
Topic Contributed
|
Date/Time:
|
Monday, August 10, 2015 : 2:00 PM to 3:50 PM
|
Sponsor:
|
Biopharmaceutical Section
|
Abstract #314776
|
View Presentation
|
Title:
|
Unblinded Sample-Size Reassessment in Time-to-Event Clinical Trials
|
Author(s):
|
Dominic Magirr*
|
Companies:
|
|
Keywords:
|
Adaptive clinical trials ;
Sample Size Re-estimation ;
time-to-event
|
Abstract:
|
Mid-study design modifications are becoming increasingly accepted in confirmatory clinical trials, so long as appropriate methods are applied such that error rates are controlled. It is therefore unfortunate that the important case of time-to-event endpoints is not easily handled by the standard theory. We analyze current methods that allow design modifications to be based on the full interim data, i.e., not only the observed event times but also secondary endpoint and safety data from patients who are yet to have an event. We show that the final test statistic may ignore a substantial subset of the observed event times, and that this leads to inefficiency compared to alternative sample size re-estimation strategies.
|
Authors who are presenting talks have a * after their name.
Back to the full JSM 2015 program
|
For program information, contact the JSM Registration Department or phone (888) 231-3473.
For Professional Development information, contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
2015 JSM Online Program Home
ASA Meetings Department
732 North Washington Street, Alexandria, VA 22314
(703) 684-1221 • meetings@amstat.org
Copyright © American Statistical Association.